Neuropsychiatry-Subject, Concepts, Methods, and Computational Models

Systems Biology in Psychiatric Research: From High-Throughput Data to Mathematical Modeling

Volumn , Issue , 2010, Pages 27-80

  Tretter, Felix ^a   Gebicke Haerter, Peter J ^b  

^a KLINIKUM MÜNCHEN OST   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Computational model; Neurobiology; Neuropsychiatry; Psychopathology; Theoretical psychiatry

Indexed keywords

EID: 84856363335     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527630271.ch2     Document Type: Chapter

References (109)

1. Abbott, L. and Regehr, W.G. (2004) Synaptic computation. Nature, 431, 796-803.
2. Aghajanian, G.K. and Marek, G.J. (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Research Reviews, 31, 302-312.
3. Ahmed, S.H., Graupner, M., and Gutkin, B. (2009) Computational approaches to the neurobiology of drug addiction. Pharmacopsychiatry, 42 (Suppl. 1), S144-S152.
4. Albrecht, U. (2006) Orchestration of gene expression and physiology by the circadian clock. Journal of Physiology, 100, 243-251.
5. Alon, U. (2007) Systems Biology-Design Principles of Biological Circuits, Chapman & Hall, New York.
6. Andreasen, N. (2004) Brave New Brain-Conquering Mental Illness in the Era of the Genome, Oxford University Press, New York.
7. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, text revision, 4th edn, American Psychiatric Association, Washington, DC.
8. Bear, M.F., Connors, B.W., and Paradiso, M.A. (2001) Neuroscience: Exploring the Brain, 2nd edn, Lippincott Williams & Wilkins, Baltimore, MD.
9. Benes, F.M. (2009) Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate or something else? Biological Psychiatry, 65, 1003-1005.
10. Benkert, O. and Hippius, H. (2008) Kompendium der Psychiatrischen Pharmakotherapie, 7th edn, Springer, Berlin.
11. Berns, G.S. and Sejnowski, T.J. (1998) A computational model of how the basal ganglia produce sequences. Journal of Cognitive Neuroscience, 10, 108-121.
12. Bhave, S.V., Hornbaker, C., Phang, T.L., Saba, L., Lapadat, R., Kechris, K., Gaydos, J., McGoldrick, D., Dolbey, A., Leach, S., Soriano, B., Ellington, A., Ellington, E., Jones, K., Mangion, J., Belknap, J.K., Williams, R.W.,Hunter, L.E., Hoffman, P.L., and Tabakoff, B. (2007) The PhenoGen informatics website: tools for analyses of complex traits. BMC Genetics, 8, 59.
13. Bremner, D.J., Narayan, M., Anderson, E.R., Staib, L.H., Miller, H.L., and Charney, D.S. (2000) Hippocampal volume reduction in major depression. American Journal of Psychiatry, 157, 115-118.
14. Brunel, N. and Wang, X.-J. (2001) Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition. Journal of Computational Neuroscience, 11, 63-85.
15. Burt, T., Sederer, L., and Isgack, W.W. (eds.) (2002) Outcome Management in Psychiatry. The Critical Review, American Psychiatry Press, Washington, DC.
16. Canli, T., Cooney, R.E., Goldin, P., Shah, M., Sivers, H., Thomason, M.E., Whit, S., Whitfield-Gabrieli, S., Gabrieli, J.D.E., and Gotlib, I.H. (2005) Amygdala reactivity to emotional faces predicts improvement in major depression. NeuroReport, 16, 1267-1270.
17. Carlsson, A. (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 1, 179-186.
18. Carlsson, A. (2006) The neurochemical circuitry of schizophrenia. Pharmacopsychiatry, 39 (Suppl. 1), S10-S14.
19. Carlsson, A., Waters, N., and Carlsson, M.L. (1999) Neurotransmitter interactions in schizophrenia- therapeutic implications. European Archives of Psychiatry and Clinical Neuroscience, 4 (Suppl.), IV-37-IV-43.
20. Cohen, J.D. and Servan-Schreiber, D. (1993) A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophrenia Bulletin, 19, 85-104.
21. Conrad, E.D. and Tyson, J.J. (2006) Modeling molecular interaction networks with nonlinear ordinary differential equations, in System Modeling in Cellular Biology: From Concepts to Nuts and Bolts (eds. Z. Szallasi, J. Stelling, and V. Periwal), MIT Press, Cambridge, MA, pp. 97-124.
22. Cooper, J.R., Bloom, F.E., and Roth, R.H. (2004) The Biochemical Basis of Neuropharmacology, 8th edn, Oxford University Press, Oxford.
23. Dayan, P. and Abbott, L. (2005) Theoretical Neuroscience. Computational and Mathematical Modeling of Neural Systems, MIT Press, Cambridge, MA.
24. Durstewitz, D. (2006) A few important points about dopamine's role in neural network dynamics. Pharmacopsychiatry, 39 (Suppl. 1), S1-S88.
25. Durstewitz, D., Seamans, J.K., and Sejnowski, T.J. (2000) Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. Journal of Neurophysiology, 83, 1733-1750.
26. Fernandez, E., Schlappe, R., Girault, J.-A., and Le Novere, N. (2006) DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Computational Biology, 2, e176.
27. Freeman, W.J. (2000) Neurodynamics: An Exploration in Mesoscopic Brain Dynamics, Springer, Berlin.
28. Gallinat, J., Obermayer, K., and Heinz, A. (2007) Systems neurobiology of the dysfunctional brain. Pharmacopsychiatry, 40 (Suppl. 1), S40-S44.
29. Gazzaniga, M. (2004) The Cognitive Neurosciences III, 3rd edn, MIT Press, Cambridge, MA.
30. Gebicke-Haerter, P.J. (2006) Expression profiling in brain disorders and beyond. Nihon Shinkei Seishin Yakurigaku Zasshi, 26, 1-10.
31. Gebicke-Haerter, P. (2008) Systems biology in molecular psychiatry. Pharmacopsychiatry, 41 (Suppl. 1), S19-S27.
32. Goldman-Rakic, P.S. (1995) Cellular basis of working memory. Neuron, 14, 477-485.
33. Goldman-Rakic, P.S. (1999) The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biological Psychiatry, 456, 650-661.
34. Goldman-Rakic, S.P., Muly, E.C. III, and Williams, G.V. (2000) D1 receptors in prefrontal cells and circuits. Brain Research Reviews, 31, 295-301.
35. Grant, S.G.N. (2003) Systems biology in neuroscience: bridging genes to cognition. Current Opinion in Neurobiology, 13,577-582.
36. Griesinger, W. (1845) Die Pathologie und Therapie der psychischen Krankheiten. Krabbe, Stuttgart.
37. Griesinger, W. (1882) Mental Pathology and Therapeutics, William Wood & Co., New York.
38. Hakak, Y., Walker, J.R., Li, C., Wong, W.H., Davis, K.L., Buxbaum, J.D.,Haroutunian, V., and Fienberg, A.A. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 98, 4746-4751.
39. Harrison, P.J. and Weinberger, D.R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 10, 40-68.
40. Heinz, A., Siessmeier, T.,Wrase, J.,Hermann, D., Klein, S., Gr€usser, S.M., Flor, H., Braus, D.F., Buchholz, H.G., Gr€under, G., Schreckenberger, M., Smolka, M.N., R€osch, F., Mann, K., and Bartenstein, P. (2004) Correlation between dopamine D2 receptors in the ventral striatum and central processing of alcohol cues and craving. American Journal of Psychiatry, 161, 1783-1789.
41. Helms, V. (2008) Principles of Computational Cell Biology, Wiley-VCH Verlag GmbH, Weinheim.
42. Hirayama, J. and Sassone-Corsi, P. (2005) Structural and functional features of transcription factors controlling the circadian clock. Current Opinion inGenetics & Development, 15, 548-556.
43. Hoffman, R.E. and Dobscha, S.K. (1989) Cortical pruning and the development of schizophrenia: a computer model. Schizophrenia Bulletin, 15, 477.
44. Hoffman, R.E. and McGlashan, T.H. (2006) Using a speech perception neural network computer simulation to contrast neuroanatomic versus neuromodulatory models of auditory hallucinations. Pharmacopsychiatry, 39 (Suppl. 1), S54-S64.
45. Jacob, F. and Monod, J. (1961) Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology, 3,318-356.
46. Kawaguchi, Y. and Kubota, Y. (1997) GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cerebral Cortex, 7, 476-486.
47. Kitano, H. (2002a) Systems biology: a brief overview. Science, 295, 1662-1664.
48. Kitano, H. (2002b) Computational systems biology. Nature, 420, 206-210.
49. Klipp, E.,Herwig, R., Kowald, A., Wielring, C., and Lehrach, H. (2005) Systems Biology in Practice, Wiley-VCH Verlag GmbH, Weinheim.
50. Klipp, E., Liebermeister, W., Wierling, Ch., Kowald, A., Lehrach, H., and Herwig, R. (2009) Systems Biology: A Textbook, Wiley- VCH Verlag GmbH, Weinheim.
51. Koch, M. (2006) Animal Models of Neuropsychiatric Diseases, Imperial College Press, London.
52. Kraepelin, E. (1902) Clinical Psychiatry, Macmillan, New York.
53. Lewis, D.L., Hashimoto, T., and Volk, D.W. (2005) Cortical inhibitory neurons and schizophrenia. Nature Reviews Neuroscience, 6, 312-324.
54. Lindskog, M. (2008) Modelling of DARPP32 regulation to understand intracellular signaling in psychiatric disorder. Pharmacopsychiatry, 41 (Suppl. 1), S99-S104.
55. Lindskog, M., Kim, M.S., Wikstrom, M.A., Blackwell, K.T., and Kotaleski, J.H. (2006) Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation. PLoS Computational Biology, 2, e119.
56. McGuffin, P., Owen, M.J., and Gottesman, I.I. (eds.) (2004) Psychiatric Genetics and Genomics, Oxford University Press, New York.
57. Meisenzahl, E.M., Scheuerecker, J., Schmitt, G.J.S., and M€oller, H.-J. (2007) Dopamine, prefrontal cortex and working memory functioning in schizophrenia. Pharmacopsychiatry, 40 (Suppl. 1), S62-S72.
58. Meyer-Lindenberg, A. and Weinberger, D.R. (2006) Intermediate phenotypes. and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience, 10, 818-827.
59. Moghaddam, B. (2003) Bringing order to the glutamate chaos in schizophrenia. Neuron, 40, 881-884.
60. Moghaddam, B. and Homayoun, H. (2008) Divergent plasticity of prefrontal cortex networks. Neuropsychopharmacology Reviews, 33, 42-55.
61. Nicholls, J.G.,Martin, A.R.,Wallace, B.G., and Fuchs, P.A. (2001) From Neuron to Brain: A Cellular and Molecular Approach to the Function of the Nervous System, 4th edn, Sinauer Associates, New York.
62. Noble, D. (2006a) The Music of Life: Biology Beyond theGenome, Oxford University Press, New York.
63. Noble, D. (2006b) Multilevel modelling in systems biology: from cells to whole organs, in System Modelling in Cellular Biology: From Concepts to Nuts and Bolts (eds. Z. Szallasi, V. Periwal, and J. Stelling), MIT Press, Cambridge, MA, pp. 297-312.
64. Palsson, B.O. (2006) Systems Biology, Cambridge University Press, Cambridge.
65. Paulsson, J. and Elf, J. (2006) Modeling molecular of intracellular kinetics, in System Modelling in Cellular Biology: From Concepts to Nuts and Bolts (eds. Z. Szallasi, V. Periwal, and J. Stelling), MIT Press, Cambridge, MA, pp. 149-176.
66. Pocklington, A.J., Cumiskey, M., Armstrong, J.D., and Grant, S.G. (2006) The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Molecular Systems Biology, 2, 2006.0023.
67. Povysheva, N.V., Zaitsev, A.V., Kr€oner, S., Krimer, O.A., Rotaru, D.C., Gonzalez-Burgos, G., Lewis, D.A., and Krimer, L.S. (2007) Electrophysiological differences between neurogliaform cells from monkey and rat prefrontal cortex. Journal of Neurophysiology, 97, 1030-1039.
68. Puls, I. and Gallinat, J. (2008) The concept of endophenotypes in psychiatric diseases-meeting the expectations? Pharmacopsychiatry, 41 (Suppl.), S37-S43.
69. Reckow, S., Gormanns, P., Holsboer, F., and Turck, C.W. (2008) Psychiatric disorders biomarker identification: from proteins to systems biology. Pharmacopsychiatry, 41 (Suppl.), S70-S77.
70. Rohlff, C. and Hollis, K. (2003) Modern proteomic strategies in the study of complex neuropsychiatric disorders. Biological Psychiatry, 53, 847-853.
71. Sadock, B.J., and Sadock, V.A. (2005) Kaplan's and Sadock's Synopsis of Psychiatry, 9th edn, Lippincott Williams & Wilkins, Philadelphia, PA.
72. Sadock, B.J., and Sadock, V.A. (2007) Kaplan's and Sadock's Synopsis of Psychiatry, 10th edn, Lippincott Williams & Wilkins, Philadelphia, PA.
73. Schl€osser, R.G.M., Koch, C., and Wagner, G. (2007) Assessing the state space of the brain with fMRI: an integrative view of current methods. Pharmacopsychiatry, 40 (Suppl. 1), S85-S92.
74. Seamans, J.K., and Yang, C.R. (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progress in Neurobiology, 74, 1-57.
75. Seamans, J.K., Durstewitz, D., Christie, B., Stevens, C.F., and Sejnowski, T.J. (2001) Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proceedings of the National Academy of Sciences of the United States of America, 98, 301-306.
76. Shepherd, G. (1994) Neurobiology, Oxford University Press, New York.
77. Shepherd, G. (2004) The Synaptic Organization of the Brain, Oxford University Press, New York.
78. Singer, W. (1999) Neuronal synchrony: a versatile code for the definition of relations? Neuron, 24, 49-65.
79. Stahl, S. (2008a) Stahl's Essential Psychopharmaocology, Cambridge University Press, Cambridge.
80. Stahl, S. (2008b) Depression and Bipolar Disorder: Stahl's Essential Psychopharmacology, 3rd edn, Cambridge University Press, New York.
81. Symond, M.P., Harris, A.W., Gordon, E., and Willams, L.M. (2005) "Gamma synchrony" in first-episode schizophrenia : a disorder of temporal connectivity? Am. J.Psychiatry, 162, 459-465.
82. Szallasi, Z., Stelling, J., and Periwal, V. (eds.) (2006) System Modelling in Cellular Biology: From Concepts to Nuts and Bolts, MIT Press, Cambridge, MA.
83. Taylor, M.A. and Vaidya, N.A. (2009) Descriptive Psychopathology, Cambridge University Press, Cambridge.
84. Thome, J. (2004) Molekulare Psychiatrie, Huber, Bern.
85. Tkachev, D., Mimmack, M.L., Ryan, M.M., Wayland, M., Freeman, T., Jones, P.B., Starkey, M.,Webster, M.J., Yolken, R.H., and Bahn, S. (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet, 362, 798.
86. Tretter, F. (2005) Systemtheorie im klinischen Kontext, Pabst, Lengerich.
87. Tretter, F. and Albus, M. (2007) "Computational neuropsychiatry" of working memory disorders in schizophrenia: the network connectivity in prefrontal cortex-data and models. Pharmacopsychiatry, 40 (Suppl. 1), S2-S16.
88. Tretter, F. and Albus, M. (2008) Systems biology and psychiatry-modeling molecular and cellular networks of mental disorders. Pharmacopsychiatry, 41 (Suppl. 1), S2-S18, Review.
89. Tretter, F. and M€uller, W. (eds.) (2007) Computational neuropsychiatry volume 2: the functional architecture of working memory networks in schizophrenia-data and models. Pharmacopsychiatry, 40 (Suppl. 1).
90. Tretter, F. and Scherer, J. (2006) Schizophrenia, neurobiology and the methodology of systemic modeling. Pharmacopsychiatry, 39 (Suppl. 1), S26-S32.
91. Tretter, F., M€uller, W., and Carlsson, A. (eds.) (2006) Systems science, computational science and neurobiology of schizophrenia. Pharmacopsychiatry, 39 (Suppl. 1).
92. Tretter, F., Gallinat, J., and M€uller, W.E. (eds.) (2008) Systems biology and psychiatry: the functional architecture of molecular networks in mental disorders-data and models. Pharmacopsychiatry, 41 (Suppl. 1).
93. Tretter, F., Gebicke-Haerter, P., and Heinz, A. (eds.) (2009) Systems biology of addiction. Pharmacopsychiatry, 42 (Suppl. 1).
94. Ueda, H.R. (2007) Systems biology of mammalian circadian clocks. Cold Spring Harbor Symposia on Quantitative Biology, 72, 365-380.
95. Van der Zee, E.A., Boersma, G.J., and Hut, R.A. (2009) The neurobiology of circadian rhythms. Current Opinion in Pulmonary Medicine, 15, 534-539.
96. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J. et al. (2001) The sequence of the human genome. Science, 291, 1304-1351.
97. Virchow, R. (1971) Die Cellularpathologie in ihrer Begr€undung auf physiologische und pathologische Gewebelehre (transl. F. Chance), Dover, New York.
98. von Bertalanffy, L. (1968) General System Theory, Braziller, New York.
99. Yang, C.R. and Chen, L. (2005) Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment. Neuroscientist, 11, 452-470.
100. Yang, C.R., Seamans, J.K., and Gorelova, N. (1999) Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology, 21, 161-194.
101. Wang, X.J., Tegnéer, J., Constandinidis, C., and Goldman-Rakic, P.S. (2004) Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. Proceedings of the National Academy of Sciences of the United States of America, 101, 1368-1373.
102. Wang, X.J. (2006) Toward a microcircuit model for cognitive deficits in schizophrenia. Pharmacopsychiatry, 39 (Suppl. 1), S80-S87.
103. Wassef, A., Baker, J., and Kochan, L.D. (2003) GABA and schizophrenia: a review of basic science and clinical studies. Journal of Clinical Psychopharmacology, 23, 601-640.
104. Webster, R. (ed.) (2002) Neurotransmitters, Drugs and Brain Function, John Wiley & Sons, Inc., New York.
105. WHO (1992) ICD-10: International Statistical Classification of Diseases and Related Health Problems, 10th revision. WHO, Geneva.
106. Wilson, C.J. and Kawaguchi, Y. (1996) The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. Journal of Neuroscience, 16, 2397-2410.
107. Winterer, G. (2006) Cortical microcircuits in schizophrenia-the dopamine hypothesis revisited. Pharmacopsychiatry, 39 (Suppl. 1), S68-S71.
108. Winterer, G. and Weinberger, D.R. (2004) Genes, dopamine and cortical signal-tonoise- ratio in schizophrenia. Trends in Neurosciences, 27, 683-690.
109. Zaccalo, M. and Pozzon, T. (2003) cAMP and Ca2{thorn} interplay: a matter of oscillation patterns. Trends in Neuroscience, 26, 53-55.